Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Alpert

Showing results (321-330 of 377) with videos related to

Pageof 38
Sort By:
Journal of Affective Disorders|November 4, 2017
Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]D Mischoulon, L Hylek, A S Yeung, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|December 2, 2006
Virtual reality, telemedicine, web and data processing innovations in medical and psychiatric education and clinical careDonald M Hilty, Dale C Alverson, Jonathan E Alpert, et al.
Psychological Medicine|May 1, 1997
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implicationsJ E Alpert, L A Uebelacker, N E McLean, et al.
The International Journal of Neuropsychopharmacology|May 10, 2005
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetineGeorge I Papakostas, Timothy Petersen, Barry D Lebowitz, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 2, 2007
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extensionMaurizio Fava, A John Rush, Jonathan E Alpert, et al.
General Hospital Psychiatry|September 12, 2020
A Bronx tale: Exposure, containment and care on inpatient psychiatry units during COVID-19Sharon Spitzer Sverd, Laura E Gardner, Johanna A Cabassa, et al.
Journal of Clinical Psychopharmacology|August 10, 1999
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorderM Fava, J F Rosenbaum, A R Kolsky, et al.
Journal of Affective Disorders|July 10, 2002
Body dysmorphic disorder in outpatients with major depressionAndrew A Nierenberg, Katharine A Phillips, Timothy J Petersen, et al.
Journal of Affective Disorders|November 17, 2007
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) studyAndrew A Nierenberg, Jonathan E Alpert, Bradley N Gaynes, et al.
Psychotherapy and Psychosomatics|February 26, 2003
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacksJonathan E Alpert, Timothy Petersen, Pamela A Roffi, et al.
Pageof 38

Showing results (321-330 of 377) with videos related to

Sort By:
Pageof 38
Journal of Affective Disorders|November 4, 2017
Corrigendum to "Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants" [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1]D Mischoulon, L Hylek, A S Yeung, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|December 2, 2006
Virtual reality, telemedicine, web and data processing innovations in medical and psychiatric education and clinical careDonald M Hilty, Dale C Alverson, Jonathan E Alpert, et al.
Psychological Medicine|May 1, 1997
Social phobia, avoidant personality disorder and atypical depression: co-occurrence and clinical implicationsJ E Alpert, L A Uebelacker, N E McLean, et al.
The International Journal of Neuropsychopharmacology|May 10, 2005
The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetineGeorge I Papakostas, Timothy Petersen, Barry D Lebowitz, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 2, 2007
What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extensionMaurizio Fava, A John Rush, Jonathan E Alpert, et al.
General Hospital Psychiatry|September 12, 2020
A Bronx tale: Exposure, containment and care on inpatient psychiatry units during COVID-19Sharon Spitzer Sverd, Laura E Gardner, Johanna A Cabassa, et al.
Journal of Clinical Psychopharmacology|August 10, 1999
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorderM Fava, J F Rosenbaum, A R Kolsky, et al.
Journal of Affective Disorders|July 10, 2002
Body dysmorphic disorder in outpatients with major depressionAndrew A Nierenberg, Katharine A Phillips, Timothy J Petersen, et al.
Journal of Affective Disorders|November 17, 2007
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) studyAndrew A Nierenberg, Jonathan E Alpert, Bradley N Gaynes, et al.
Psychotherapy and Psychosomatics|February 26, 2003
Behavioral and emotional disturbances in the offspring of depressed parents with anger attacksJonathan E Alpert, Timothy Petersen, Pamela A Roffi, et al.
Pageof 38